Atlas Trials

Inflammatory Regulation Effect of NAC on COVID-19 Treatment

Clinical trial NCT04455243 · UNKNOWN

Trial details

NCT number
NCT04455243
Sponsor
Dr. Tariq Alhawassi
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-08-01
Primary completion
2021-08-30
Enrollment
1180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.